First Time Loading...
N

Nanjing Vazyme Biotech Co Ltd
SSE:688105

Watchlist Manager
Nanjing Vazyme Biotech Co Ltd
SSE:688105
Watchlist
Price: 22.17 CNY -3.65% Market Closed
Updated: Jun 3, 2024

Nanjing Vazyme Biotech Co Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nanjing Vazyme Biotech Co Ltd
Total Liabilities & Equity Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
N
Nanjing Vazyme Biotech Co Ltd
SSE:688105
Total Liabilities & Equity
¥5.7B
CAGR 3-Years
53%
CAGR 5-Years
87%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Total Liabilities & Equity
¥41.1B
CAGR 3-Years
4%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Total Liabilities & Equity
¥20.6B
CAGR 3-Years
20%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Total Liabilities & Equity
¥15.7B
CAGR 3-Years
65%
CAGR 5-Years
54%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Total Liabilities & Equity
¥50.2B
CAGR 3-Years
43%
CAGR 5-Years
43%
CAGR 10-Years
34%
Imeik Technology Development Co Ltd
SZSE:300896
Total Liabilities & Equity
¥6.3B
CAGR 3-Years
103%
CAGR 5-Years
74%
CAGR 10-Years
N/A

See Also

What is Nanjing Vazyme Biotech Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
5.7B CNY

Based on the financial report for Dec 31, 2023, Nanjing Vazyme Biotech Co Ltd's Total Liabilities & Equity amounts to 5.7B CNY.

What is Nanjing Vazyme Biotech Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
87%

Over the last year, the Total Liabilities & Equity growth was -4%. The average annual Total Liabilities & Equity growth rates for Nanjing Vazyme Biotech Co Ltd have been 53% over the past three years , 87% over the past five years .